(Q51411699)

5 April 2018

title

Inverse relationship between serum high density lipoprotein and negative syndrome in antipsychotic-naive schizophrenia. (English)

1 reference

5 April 2018

Ganesan Venkatasubramanian

1 reference

1

1 reference

5 April 2018

Sunil V. Kalmady

5

1 reference

5 April 2018

Bengaluru Gangadhar

6

1 reference

5 April 2018

Rishikesh V Behere

object named as

Rishikesh V Behere

4

0 references

author name string

Rashmi Arasappa

2

1 reference

5 April 2018

Naren P Rao

3

1 reference

5 April 2018

publication date

1 January 2010

1 reference

5 April 2018

Clinical Chemistry and Laboratory Medicine

published in

1 reference

5 April 2018

volume

48

1 reference

5 April 2018

issue

1

1 reference

5 April 2018

page(s)

95-98

1 reference

5 April 2018

Implications of lipid biology for the pathogenesis of schizophrenia

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.004

Lipid metabolism, human evolution and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.004

The neurobiology of apolipoproteins in psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.004

Gene expression analysis in schizophrenia: reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.004

Apolipoprotein L, a new human high density lipoprotein apolipoprotein expressed by the pancreas. Identification, cloning, characterization, and plasma distribution of apolipoprotein L

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.004

Serum lipids and hippocampal volume: the link to Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.004

High density lipoprotein fatty acids in dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.004

Automated MRI parcellation study of regional volume and thickness of prefrontal cortex (PFC) in antipsychotic-naïve schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.004

The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.004

The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.004

Insulin and insulin-like growth factor-1 abnormalities in antipsychotic-naive schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.004

Cholesterol metabolism in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.004

Psychiatric disorders and behavioral problems in children with velocardiofacial syndrome: usefulness as phenotypic indicators of schizophrenia risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.004

21 January 2018

Identifiers

DOI

10.1515/CCLM.2010.004

1 reference

5 April 2018

1 reference

5 April 2018